Virogin Biotech Ltd's Headquarters in Canada, located by University of British Columbia’s (UBC) Vancouver campus

Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. We are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using our novel Synerlytic™ technical platform for improved cancer treatment.

By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.